Advertisement

Medicinal Chemistry Research

, Volume 28, Issue 8, pp 1284–1297 | Cite as

Design, synthesis, biological evaluation and molecular modeling of new coumarin derivatives as potent anticancer agents

  • Eman A. FayedEmail author
  • Rehab Sabour
  • Marwa F. HarrasEmail author
  • Ahmed B. M. Mehany
Original Research

Abstract

A novel series of coumarin-pyridine/fused pyridine hybrids were designed and synthesized. Their anticancer activity was evaluated against human cancer cell lines MCF-7, HCT-116, HepG-2, and A549. Compounds 9, 10, and 11 showed the most potent growth inhibitory activities with IC50 values ranging from 1.1 to 2.4 μM, against MCF-7 cell line. Flow cytometric analysis revealed that these compounds induced cell cycle arrest in the G2/M phase followed by apoptotic cell death. Consistent with these results, the activity of caspase-3 in MCF-7 cells was tested. The results indicated that compounds 9, 10, and 11 increased caspase-3 activity significantly compared to control group. Moreover, their binding affinity for caspase-3 was confirmed by docking study. Taking all these data together, it is suggested that these coumarin derivatives may be potential antiproliferative agents.

One-pot synthesis of new coumarin derivatives: design, synthesis, molecular modeling and biological evaluation as potent anticancer agents. New coumarin hybrids were evaluated as antiproliferative agents, compounds 9, 10 and 11 induced G2/M arrest and apoptosis through stimulation of caspase-3.

Keywords

Coumarin-pyridine Docking Anticancer Cell cycle and caspase-3 enzyme 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

44_2019_2373_MOESM1_ESM.pdf (531 kb)
Supplementary Information

References

  1. Benci K, Mandić L, Suhina T, Sedić M, Klobučar M, Pavelić SK, Pavelić K, Wittine K, Mintas M (2012) Novel coumarin derivatives containing 1,2,4-triazole, 4,5-dicyanoimidazole and purine moieties: synthesis and evaluation of their cytostatic activity. Molecules 17:11010–11025.  https://doi.org/10.3390/molecules170911010 CrossRefGoogle Scholar
  2. Blank M, Shiloh Y (2007) Programs for cell death: apoptosis is only one way to go. Cell Cycle 6:686–695.  https://doi.org/10.4161/cc.6.6.3990 CrossRefGoogle Scholar
  3. Chan KT, Meng FY, Li Q, Ho CY, Lam TS, To Y, Lee WH, Li M, Ch KH, Toh M (2010) Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. Cancer Lett 294:118–124.  https://doi.org/10.1016/j.canlet.2010.01.029 CrossRefGoogle Scholar
  4. Eissa SI (2017) Synthesis, characterization and biological evaluation of some new indomethacin analogs with a colon tumor cell growth inhibitory activity. Med Chem Res 26:2205–2220.  https://doi.org/10.1007/s00044-017-1932-8 CrossRefGoogle Scholar
  5. El-Gaby MSA, Abdel-Gawad SM, Ghorab MM, Heiba HI, Aly HM (2006) Synthesis and biological activity of some novel thieno[2,3-b]quinoline, quinolino[3’,2’:4,5]thieno[3,2-d]pyrimidine and pyrido[2’,3’:4,5]thieno[2,3-b]quinoline derivatives. Phosphorus Sulfur Silicon Relat Elem 181:279–297.  https://doi.org/10.1080/104265090970322
  6. Fan CD, Su H, Zhao J, Zhao BX, Zhang SL, Miao JY (2010) A novel copper complex of salicylaldehyde pyrazole hydrazone induces apoptosis through upregulating integrin β4 in H322 lung carcinoma cells. Eur J Med Chem 45:1438–1446.  https://doi.org/10.1016/j.ejmech.2009.12.048
  7. Juliana PMG, Cássia RPC, Eliana AV, José-Manuel M, Mariana FF, Nicolás O, Iracilda Z, Wagner V (2011) Antitumoral, mutagenic and (anti)estrogenic activities of tingenone and pristimerin. Rev Bras Farmacogn 21:963–971.  https://doi.org/10.1590/S0102-695X2011005000153 CrossRefGoogle Scholar
  8. Kamal A, Shaik B, Nayak VL, Nagaraju B, Kapure JS, Malik MS, Shaik TB, Prasad B (2014) Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers. Bioorg Med Chem 22:5155–5167.  https://doi.org/10.1016/j.bmc.2014.08.008 CrossRefGoogle Scholar
  9. Kini SG, Choudhary S, Mubeen M (2012) Synthesis, docking study and anticancer activity of coumarin substituted derivatives of benzothiazole. J Comput Methods Mol Des 2:51–60Google Scholar
  10. Lee D, Long SA, Adams JL, Chan G, Vaidya KS, Francis TA, Kikly K, Winkler JD, Sung C-M, Debouck C, Richardson S, Levy MA, DeWolf WE, Keller Jr PM, Tomaszek T, Head MS, Ryan MD, Haltiwanger RC, Liang P-H, Janson CA, McDevitt PJ, Johanson K, Concha NO, Chan W, Abdel-Meguid SS, Badger AM, Lark MW, Nadeau DP, Suva LJ, Gowen M, Nuttall ME (2000) Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J Biol Chem 275:16007–16014CrossRefGoogle Scholar
  11. Liu Y, Peterson DA, Kimura H, Schubert D (1997) Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 69:581–593CrossRefGoogle Scholar
  12. Marshall ME, Kervin K, Benefield C, Umerani A, Albainy-Jenei S, Zhao Q, Khazaeli MB (1994) Growth-inhibitory effects of coumarin (1, 2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro. J Cancer Res Clin Oncol 120:3–10CrossRefGoogle Scholar
  13. Molecular Operating Environment (MOE) (2008) 10, Chemical Computing Group Inc., Montréal, Canada. http://www.chemcomp.com
  14. Musa MA, Badisa LDV, Latinwo LM, Patterson TA, Owens AM (2012) Coumarin-based benzopyranone derivatives induced apoptosis in human lung (A549) cancer cells. Anticancer Res 32:4271–4276Google Scholar
  15. Musa MA, Joseph MY, Latinwo LM, Badisa V, Cooperwood JS (2015) In vitro evaluation of 3-arylcoumarin derivatives in A549 cell line. Anticancer Res 35:653–659Google Scholar
  16. Nadia HM, Emad AD (2018) Synthesis, anticancer assessment on human breast, liver and colon, carcinoma cell lines and molecular modeling study using novel pyrazolo[4,3-c]pyridine derivatives. Bioorg Chem 77:203–214.  https://doi.org/10.1016/j.bioorg.2017.12.032 CrossRefGoogle Scholar
  17. Nagaraju K, Parvesh S, Neil K, Raghu R, Vipan K (2017) Recent advances (2015-2016) in anticancer hybrids. Eur J Med Chem 142:179–212.  https://doi.org/10.1016/j.ejmech.2017.07.033 CrossRefGoogle Scholar
  18. Nepali K, Sharma S, Sharma M, Bedi PMS, Dhar KL (2014) Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. Eur J Med Chem 77:422–487.  https://doi.org/10.1016/j.ejmech.2014.03.018 CrossRefGoogle Scholar
  19. Paul K, Bindal S, Luxami V (2013) Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity. Bioorg Med Chem Lett 23:3667–3672.  https://doi.org/10.1016/j.bmcl.2012.12.071 CrossRefGoogle Scholar
  20. Reed JC (2000) Mechanisms of apoptosis. Am J Pathol 157:1415–1430.  https://doi.org/10.1016/S0002-9440(10)64779-7 CrossRefGoogle Scholar
  21. Salem MA, Marzouk MI, El-Kazak AM (2016) Synthesis and characterization of some new coumarins with in vitro antitumor and antioxidant activity and high protective effects against DNA damage. Molecules.  https://doi.org/10.3390/molecules21020249
  22. Sashidhara KV, Avula SR, Sharma K, Palnati GR, Bathula SR (2013) Discovery of coumarin–monastrol hybrid as potential antibreast tumor-specific agent. Eur J Med Chem 60:120–127.  https://doi.org/10.1016/j.ejmech.2012.11.044 CrossRefGoogle Scholar
  23. Sashidhara KV, Kumar A, Kumar M, Sarkar J, Sinha S (2010) Synthesis and in vitro evaluation of novel coumarin–chalcone hybrids as potential anticancer agents. Bioorg Med Chem Lett 20:7205–7211.  https://doi.org/10.1016/j.bmcl.2010.10.116 CrossRefGoogle Scholar
  24. Shen JK, Du HP, Yang M, Wang YG, Jin J (2009) Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Ann Hematol 88:743–752.  https://doi.org/10.1007/s00277-008-0677-3 CrossRefGoogle Scholar
  25. Siddiqi N, Arshad F, Khan S (2009) Synthesis of some new coumarin incorporated thiazolyl symicarbazones as anticonvulsants. Pharm Soci 66:161–167Google Scholar
  26. Singh KR, Lange ST, Kim KK (2011) A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells. Invest New Drugs 29:63–72.  https://doi.org/10.1007/s10637-009-9335-4 CrossRefGoogle Scholar
  27. Vosooghi M, Rajabalian S, Sorkhi M, Badinloo M, Nakhjiri M, Negahbani AS, Asadipour A, Mahdavi MA (2010) Synthesis and cytotoxic activity of some 2-amino-4-aryl-3-cyano-7-(dimethylamino)-4 H-chromenes. Res Pharm Sci 5:9–14Google Scholar
  28. Zhao P, Chen L, Li L, Wei Z, Tong B, Jia Y, Kong L, Xia Y, Dai Y (2014) SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation. BMC Cancer 14:987.  https://doi.org/10.1186/1471-2407-14-987 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy (Girls)Al-Azhar UniversityCairoEgypt
  2. 2.Pharmaceutical Chemistry Department, Faculty of PharmacyAl-Azhar University (Girls)CairoEgypt
  3. 3.Department of Zoology, Faculty of Science (Boys)Al-Azhar UniversityCairoEgypt

Personalised recommendations